You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 121 No. 3, March 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinicopathologic Reports, Case Reports, and Small Case Series
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Usher Syndrome Type 1 Associated With Primary Ciliary Aplasia

Arch Ophthalmol. 2003;121:407-408.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Usher syndrome (USH) is an autosomal recessive defect that affects both the inner ear and retina. It is regarded as the most frequent cause of deafness-blindness in humans. Three clinical subtypes have been described, of which the most severe form, USH type 1 (USH1), is characterized by profound congenital sensorineural hearing loss, constant vestibular dysfunction, and prepubertal onset of retinitis pigmentosa.

Primary ciliary aplasia, a rare form of primary ciliary dyskinesia, is a congenital disorder of the mucociliary apparatus characterized by a total absence of epithelial cilia in cells that show the other ultrastructural features of normal ciliated cells. It is characterized by chronic infections of the upper and lower respiratory tract and by male infertility. The absence of cilia and basal bodies in respiratory mucosa makes it possible to distinguish primary ciliary aplasia from acquired ciliary defects.

Report of a Case

A 10-year-old boy whose speech was hardly intelligible had been diagnosed as . . . [Full Text of this Article]


Comment
Corresponding author and reprints: Pietro Luzi, MD, Department of Human Pathology and Oncology, University of Siena, Nuovo Policlinico "Le Scotte," Via delle Scotte, 6, 53100 Siena, Italy (e-mail: luzi@unisi.it).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.